1. Zhang, Yaguang, Wan, Xiaowen, Yang, Xuyang, Zhang, Bo, Han, Junhong. 2023. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation. In The Journal of biological chemistry, 299, 105177. doi:10.1016/j.jbc.2023.105177. https://pubmed.ncbi.nlm.nih.gov/37611825/
2. Xiao, Wen, Zhang, Weiyi, Huang, Hai, Chen, Guo, Song, Xiangrong. 2019. Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes. In Molecular pharmaceutics, 17, 229-238. doi:10.1021/acs.molpharmaceut.9b00943. https://pubmed.ncbi.nlm.nih.gov/31765158/
3. Li, Bei, Xiong, Xianze, Xu, Jianrong, Wang, Yaoqun, Lu, Jiong. 2024. METTL3-mediated m6A modification of lncRNA TSPAN12 promotes metastasis of hepatocellular carcinoma through SENP1-depentent deSUMOylation of EIF3I. In Oncogene, 43, 1050-1062. doi:10.1038/s41388-024-02970-0. https://pubmed.ncbi.nlm.nih.gov/38374407/
4. Zhang, Yaguang, Wang, Ping, Zhang, Qian, Song, Xiangrong, Yao, Shaohua. . eIF3i activity is critical for endothelial cells in tumor induced angiogenesis through regulating VEGFR and ERK translation. In Oncotarget, 8, 19968-19979. doi:10.18632/oncotarget.15274. https://pubmed.ncbi.nlm.nih.gov/28193911/
5. Kuai, Le, Xiang, Yan-Wei, Chen, Qi-Long, Luo, Yue, Li, Bin. 2021. PD-L1 Triggered by Binding eIF3I Contributes to the Amelioration of Diabetes-Associated Wound Healing Defects by Regulating IRS4. In The Journal of investigative dermatology, 142, 220-231.e8. doi:10.1016/j.jid.2021.06.028. https://pubmed.ncbi.nlm.nih.gov/34293353/